Pentax Pharma Pvt Ltd
About Pentax Pharma Pvt Ltd
Data last updated:
Pentax Pharma Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the commercial printing services segment of the media and publishing sector. It was incorporated on 07 September 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24139MH1992PTC068429. Its GSTIN is 27AAACP4910B1ZY (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1.82 Lakh. It is led by directors Gautam Sampatraj Jain and Pragnyat Pravin Lalwani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.32 Cr, a growth of 113% compared to the previous year. For the same year it recorded a net profit of ₹53.76 Lakh (net margin 16.2%) and EBITDA of ₹1.25 Cr (EBITDA margin 37.6%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹8.48 Cr and satisfied charges of ₹27.04 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address9 Floor – 1 Lalwani Industrial Estate, G D Ambekar Marg Wadala, Mumbai, Maharashtra, India – 400031
- IndustryMedia and Publishing, Commercial Printing Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pentax Pharma Pvt Ltd
The main business activity of Pentax Pharma is manufacturing. In detail, this covers printing and reproduction of recorded media.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 18 | Printing and reproduction of recorded media | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pentax Pharma Pvt Ltd FY 2024 filings available
Pentax Pharma Pvt Ltd reported revenue of ₹3.32 Cr (up 113% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Pentax Pharma Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 113% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pentax Pharma Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.25 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹53.76 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pentax Pharma Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 16.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pentax Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pentax Pharma Pvt Ltd
Pentax Pharma Pvt Ltd is compared with the companies closest to it by revenue in the Media and Publishing industry (Commercial Printing, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adroit Pharma Research Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 338.0% | •••• | Vadodara, Gujarat, India |
| Vamika Medical and General Stores Private Limited | ₹3.33 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Kalyan, Maharashtra, India |
| Smile Publishing (India) Private Limited | ₹3.33 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Chennai, Tamil Nadu, India |
| Apisa Biotech Extn Private Limited | ₹3.33 Cr (FY 2024) | •••• | •••• | 62.0% | •••• | Hyderabad, Telangana, India |
| Primetone Digital Press Private Limited | ₹3.32 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Thrissur, Kerala, India |
| Pentax Pharma Pvt Ltd this company | ₹3.32 Cr (FY 2025) | •••• | •••• | 113.0% | •••• | Mumbai, Maharashtra, India |
| Selaginella Lifesciences Private Limited | ₹3.32 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Baddi, Himachal Pradesh, India |
| Suraj Digital Offset Private Limited | ₹3.32 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Jagdalpur, Chhattisgarh, India |
| Krebz Healthcare Private Limited | ₹3.31 Cr (FY 2023) | •••• | •••• | -35.0% | •••• | Chennai, Tamil Nadu, India |
| Airport Advertising (Agartala) Private Limited | ₹3.31 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Patna, Bihar, India |
| Hybrid Print Private Limited | ₹3.31 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Pentax Pharma by revenue in the Media and Publishing industry (Commercial Printing, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pentax Pharma Pvt Ltd
Pentax Pharma Pvt Ltd is audited by NEERAV M. SANGHAVI for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NEERAV M. SANGHAVI | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pentax Pharma Pvt Ltd
Pentax Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gautam Sampatraj Jain Also directs: Seshaasai Technologies Limited, Srichakra Infratech Private Limited, Prayaas Automation Private Limited and 5 more | Director | 17 Jan 1994 | 32 Years 8 Months | Current |
| Pragnyat Pravin Lalwani Also directs: Seshaasai Technologies Limited, Srichakra Infratech Private Limited, Prayaas Automation Private Limited and 4 more | Director | 07 Sep 1993 | 33 Years 1 Months | Current |
Ownership and Shareholding of Pentax Pharma Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pentax Pharma Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2019 | State Bank of India | ₹8.48 Cr | Open |
| 08 Dec 2016 | Axis Bank Limited | ₹7 Cr | Satisfied |
| 11 Dec 2013 | The Greater Bombay Co-Op Bank Ltd | ₹1.94 Cr | Satisfied |
| 11 Dec 2013 | The Greater Bombay Co-Op Bank Ltd | ₹1.58 Cr | Satisfied |
| 17 Dec 2007 | The Greater Bombay Co-Operative Bank Ltd | ₹14.27 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Pentax Pharma Pvt Ltd
Employment history and EPFO contributions of people linked to Pentax Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pentax Pharma Pvt Ltd
Pentax Pharma Pvt Ltd has 2 board changes on record since 1993: 2 appointments. The latest: Gautam Sampatraj Jain was appointed as Director on 17 Jan 1994.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pentax Pharma Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pentax Pharma Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pentax Pharma Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pentax Pharma Pvt Ltd
Pentax Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACP4910B1ZY | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pentax Pharma Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pentax Pharma Pvt Ltd
Pentax Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in commercial printing services, within the media and publishing industry. It was incorporated on 07 September 1992 (34+ years old) and is registered under CIN U24139MH1992PTC068429.
Pentax Pharma reported revenue of ₹3.32 Cr for FY 2025 (up 113% YoY).
Pentax Pharma has 2 current directors:
- Gautam Sampatraj Jain - Director
- Pragnyat Pravin Lalwani - Director
Pentax Pharma reported a net profit of ₹53.76 Lakh (net margin 16.2%) and EBITDA of ₹1.25 Cr (EBITDA margin 37.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pentax Pharma is 45% over three years and 7% over five years. In the latest year (FY 2025) revenue rose 113%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pentax Pharma is 27AAACP4910B1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pentax Pharma is U24139MH1992PTC068429. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pentax Pharma was incorporated on 07 September 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pentax Pharma by revenue are Adroit Pharma Research Private Limited, Vamika Medical and General Stores Private Limited, Smile Publishing (India) Private Limited, Apisa Biotech Extn Private Limited, Primetone Digital Press Private Limited and 5 more, all in the Media and Publishing industry (Commercial Printing, Formulations).
Gautam Sampatraj Jain was appointed as Director on 17 Jan 1994. Pragnyat Pravin Lalwani was appointed as Director on 07 Sep 1993.
The registered office of Pentax Pharma is at 9 Floor – 1 Lalwani Industrial Estate, G D Ambekar Marg Wadala, Mumbai, Maharashtra, India – 400031.